Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacrolimus

NCT06719024 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

Vitiligo

Interventions

DRUG: Ruxolitinib Cream 1.5%
DRUG: Aqueous cream

Sponsor

Hospital Authority, Hong Kong